Amgen (AMGN): FY26 Q1 earnings call, Apr 30, 2026
No Kalshi or Polymarket word markets were listed for Amgen’s Apr 30, 2026 earnings call (FY26 Q1). The transcript is searchable below (quotes of at most 25 words).
UpdatedTranscript
quotes of at most 25 wordsSpeaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.
2 matches for “Oral”; 2 quoted, at least 25 words apart.
…exposure. Stable drug levels avoid the frequent peaks and troughs of daily orals and weekly injectables that may contribute to intolerability. We remain confident and…
…the weekly GLP-1s. But different than the weekly GLP-1s and different than oral GLP-1s that are short half-life medicines, this trough to peak spike that's…
Agents: this page as TSV at /api/v1/appearances/amgen:2026-04-30:earnings_call · words: /api/v1/brief?appearance=amgen:2026-04-30:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP